Due to recent advents in the development of novel colchicine derivatives, we considered the possibility of downregulating GLUT1 via colchicine-induced microtubule destabilization to ultimately reduce the Warburg effect in GBM in hopes of attenuating the phenotypic hallmarks of cancer. This evidence concerns the gene SLC2A1 and glioblastoma.